A device to quickly detect viral proteins in nasal swabs, saliva, and blood.
A point-of-care device using Single Molecule Array (Simoa) to measure viral antigens in nasal swabs, saliva, and blood
This study is working on a simple and affordable device that helps doctors quickly diagnose viral infections like COVID-19 and the flu using samples like nasal swabs or saliva, making it easier for patients to get the care they need right away.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Quanterix Corporation NIH-funded |
| Lab location | 1 site (Billerica, UNITED STATES) |
| Project ID | NIH-10497507 on NIH RePORTER |
What this research studies
This research aims to create a user-friendly and affordable device that can diagnose viral infections at the point of care. It utilizes advanced technology to detect proteins associated with viruses, such as COVID-19 and influenza, from various sample types including nasal swabs, saliva, and blood. The device is designed to provide accurate results comparable to traditional lab tests, making it easier for healthcare providers to diagnose patients quickly and effectively. By simplifying the testing process, this device could enhance access to timely diagnostics in various healthcare settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults and children who may exhibit symptoms of viral infections like COVID-19 or influenza.
Not a fit: Patients who do not exhibit symptoms of viral infections or those who have already been diagnosed may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnoses of viral infections, improving patient outcomes.
How similar studies have performed: Other research has shown promise in using similar point-of-care diagnostic technologies, indicating potential for success in this approach.
Where this research is happening
Billerica, UNITED STATES
- Quanterix Corporation — Billerica, United States (Active)
Researchers
- Principal investigator: Duffy, David C — Quanterix Corporation
- Study coordinator: Duffy, David C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.